Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array

References

• Cancer Research UK online statistics. [cited 25th June 2015]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/.
   Google Scholar
• Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, etal. SEER cancer statistics review, 1975–2012. 2015; Bethesda, MD: National Cancer Institute.
   Google Scholar
• Amaro A, Esposito AI, Gallina A, Nees M, Angelini G, Albini A, etal. Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel. Cancer Metastasis Rev. 2014; 33: 657–71. doi: http://dx.doi.org/10.1007/s10555-013-9470-4.
   Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2: 569–79. doi: http://dx.doi.org/10.1038/nri855.
   Google Scholar
• Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, etal. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10: e1001450, doi: http://dx.doi.org/10.1371/journal.pbio.1001450.
   Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9. doi: http://dx.doi.org/10.1038/ncb1596.
   Google Scholar
• Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, etal. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24: 766–9. doi: http://dx.doi.org/10.1038/cr.2014.44.
   Google Scholar
• Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006; 66: 4795–801. doi: http://dx.doi.org/10.1158/0008-5472.can-05-4579.
   Google Scholar
• Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, etal. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Molec Cell Proteomics. 2010; 9: 1085–99. doi: http://dx.doi.org/10.1074/mcp.M900381-MCP200.
   Google Scholar
• Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005; 118: 3631–8. doi: http://dx.doi.org/10.1242/jcs.02494.
   Google Scholar
• Webber J, Yeung V, Clayton A. Extracellular vesicles as modulators of the cancer microenvironment. Semin Cell Dev Biol. 2015; 40: 27–34. doi: http://dx.doi.org/10.1016/j.semcdb.2015.01.013.
   Google Scholar
• Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005; 17: 879–87. doi: http://dx.doi.org/10.1093/intimm/dxh267.
   Google Scholar
• Pisitkun T, Shen R-F, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004; 101: 13368–73. doi: http://dx.doi.org/10.1073/pnas.0403453101.
   Google Scholar
• Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull. 2008; 31: 1059–62. doi: http://dx.doi.org/10.1248/bpb.31.1059.
   Google Scholar
• Andre F, Schartz NEC, Movassagh M, Flament C, Pautier P, Morice P, etal. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002; 360: 295–305. doi: http://dx.doi.org/10.1016/S0140-6736(02)09552-1.
   Google Scholar
• Duijvesz D, Luider T, Bangma CH, Jenster G. Exosomes as biomarker treasure chests for prostate cancer. Eur Urol. 2011; 59: 823–31. doi: http://dx.doi.org/10.1016/j.eururo.2010.12.031.
   Google Scholar
• Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, etal. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015; 523: 177–82. doi: http://dx.doi.org/10.1038/nature14581.
   Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13–21. doi: http://dx.doi.org/10.1016/j.ygyno.2008.04.033.
   Google Scholar
• Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, etal. Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006; 70: 1847–57. doi: http://dx.doi.org/10.1038/sj.ki.5001874.
   Google Scholar
• Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, etal. Exosomes: novel biomarkers for clinical diagnosis. Sci. World J. 2015; 2015: 657086, doi: http://dx.doi.org/10.1155/2015/657086.
   Google Scholar
• Kalra H, Adda CG, Liem M, Ang C-S, Mechler A, Simpson RJ, etal. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013; 13: 3354–64. doi: http://dx.doi.org/10.1002/pmic.201300282.
   Google Scholar
• Taylor DD, Chou I-N, Black PH. Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem Biophys Res Commun. 1983; 113: 470–6. doi: http://dx.doi.org/10.1016/0006-291X(83)91749-7.
   Google Scholar
• Böing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014; 3: 23430, doi: http://dx.doi.org/10.3402/jev.v3.23430.
   Google Scholar
• de Menezes-Neto A, Fidalgo Sáez MJ, Lozano-Ramos I, Segui-Barber J, Martin-Jaular L, Estanyol Ullate JM, etal. Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals. J Extracell Vesicles. 2015; 6: 27378, doi: http://dx.doi.org/10.3402/jev.v4.27378.
   Google Scholar
• Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, etal. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One. 2010; 5: e15004, doi: http://dx.doi.org/10.1371/journal.pone.0015004.
   Google Scholar
• Webber J, Stone TC, Katilius E, Smith BC, Gordon B, Mason MD, etal. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform. Mol Cell Proteomics. 2014; 13: 1050–64. doi: http://dx.doi.org/10.1074/mcp.M113.032136.
   Google Scholar
• Webber J, Clayton A. How pure are your vesicles?. J Extracell Vesicles. 2013; 2: 19861, doi: http://dx.doi.org/10.3402/jev.v2i0.19861.
   Google Scholar
• Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, etal. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010; 9: 1324–38. doi: http://dx.doi.org/10.1074/mcp.M000063-MCP201.
   Google Scholar
• Rohloff JC, Gelinas AD, Jarvis TC, Ochsner UA, Schneider DJ, Gold L, etal. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol Ther Nucleic Acids. 2014; 3: e201, doi: http://dx.doi.org/10.1038/mtna.2014.49.
   Google Scholar
• Pathan M, Keerthikumar S, Ang CS, Gangoda L, Quek CY, Williamson NA, etal. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015; 15: 2597–601. doi: http://dx.doi.org/10.1002/pmic.201400515.
   Google Scholar
• Welton JL, Webber JP, Botos LA, Jones M, Clayton A. Ready-made chromatography columns for extracellular vesicle isolation from plasma. J Extracell Vesicles. 2015; 4: 27269, doi: http://dx.doi.org/10.3402/jev.v4.27269.
   Google Scholar
• Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, etal. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics. 2013; 80: 171–82. doi: http://dx.doi.org/10.1016/j.jprot.2012.12.029.
   Google Scholar
• Looze C, Yui D, Leung L, Ingham M, Kaler M, Yao X, etal. Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun. 2009; 378: 433–8. doi: http://dx.doi.org/10.1016/j.bbrc.2008.11.050.
   Google Scholar
• Coleman BM, Hanssen E, Lawson VA, Hill AF. Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J. 2012; 26: 4160–73. doi: http://dx.doi.org/10.1096/fj.11-202077.
   Google Scholar
• Tatischeff I, Larquet E, Falcón-Pérez JM, Turpin PY, Kruglik SG. Fast characterisation of cell-derived extracellular vesicles by nanoparticles tracking analysis, cryo-electron microscopy, and Raman tweezers microspectroscopy. J Extracell Vesicles. 2012; 1: 19179, doi: http://dx.doi.org/10.3402/jev.v1i0.19179.
   Google Scholar
• Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes. 2002; 51: 1949–56.
   Web of Science ®Google Scholar
• Fernández-Llama P, Khositseth S, Gonzales PA, Star RA, Pisitkun T, Knepper MA. Tamm-Horsfall protein and urinary exosome isolation. Kidney Int. 2010; 77: 736–42. doi: http://dx.doi.org/10.1038/ki.2009.550.
   Google Scholar
• Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, etal. Large-Scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol. 2009; 20: 363–79. doi: http://dx.doi.org/10.1681/asn.2008040406.
   Google Scholar
• Wang Z, Hill S, Luther JM, Hachey DL, Schey KL. Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics. 2012; 12: 329–38. doi: http://dx.doi.org/10.1002/pmic.201100477.
   Google Scholar
• Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z, etal. Can urinary exosomes act as treatment response markers in prostate cancer?. J Transl Med. 2009; 7: 4. doi: http://dx.doi.org/10.1186/1479-5876-7-4.
   Google Scholar
• Cantin R, Diou J, Bélanger D, Tremblay AM, Gilbert C. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods. 2008; 338: 21–30. doi: http://dx.doi.org/10.1016/j.jim.2008.07.007.
   Google Scholar
• Lobb RJ, Becker M, Wen SW, Wong CS, Wiegmans AP, Leimgruber A, etal. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015; 4: 27031, doi: http://dx.doi.org/10.3402/jev.v4.27031.
   Google Scholar
• Baranyai T, Herczeg K, Onodi Z, Voszka I, Modos K, Marton N, etal. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015; 10: e0145686, doi: http://dx.doi.org/10.1371/journal.pone.0145686.
   Google Scholar
• Lozano-Ramos I, Bancu I, Oliveira-Tercero A, Armengol MP, Menezes-Neto A, Del Portillo HA, etal. Size-exclusion chromatography-based enrichment of extracellular vesicles from urine samples. J Extracell Vesicles. 2015; 4: 27369, doi: http://dx.doi.org/10.3402/jev.v4.27369.
   Google Scholar
• Kosanović M, Janković M. Isolation of urinary extracellular vesicles from Tamm-Horsfall protein–depleted urine and their application in the development of a lectin-exosome-binding assay. BioTechniques. 2014; 57: 143–9.
   PubMed Web of Science ®Google Scholar
• Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, etal. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014; 3: 26913, doi: http://dx.doi.org/10.3402/jev.v3.26913.
   Google Scholar
• Saito S, Murayama Y, Pan Y, Taima T, Fujimura T, Murayama K, etal. Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer. Int J Cancer. 2008; 123: 633–40. doi: http://dx.doi.org/10.1002/ijc.23490.
   Google Scholar
• Ikeda A, Nakagawa T, Kawai K, Onozawa M, Hayashi T, Matsushita Y, etal. Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer. Prostate Int. 2015; 3: 87–92. doi: http://dx.doi.org/10.1016/j.prnil.2015.07.001.
   Google Scholar
• Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ, etal. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem. 2012; 58: 599–609. doi: http://dx.doi.org/10.1373/clinchem.2011.171637.
   Google Scholar
• Fernandez PL, Farre X, Nadal A, Fernandez E, Peiro N, Sloane BF, etal. Expression of cathepsins B and S in the progression of prostate carcinoma. Int J Cancer. 2001; 95: 51–5. doi: http://dx.doi.org/10.1002/1097-0215(20010120)95:1<51::AID-IJC1009>3.0.CO;2-J.
   Google Scholar
• Lucarelli G, Rutigliano M, Bettocchi C, Palazzo S, Vavallo A, Galleggiante V, etal. Spondin-2, a secreted extracellular matrix protein, is a novel diagnostic biomarker for prostate cancer. J Urol. 2013; 190: 2271–7. doi: http://dx.doi.org/10.1016/j.juro.2013.05.004.
   Google Scholar
• Akudugu J, Serafin A, Bohm L. Further evaluation of uPA and PAI-1 as biomarkers for prostatic diseases. J Cancer Res Clin Oncol. 2015; 141: 627–31. doi: http://dx.doi.org/10.1007/s00432-014-1848-3.
   Google Scholar
• Liu Y, Pixley R, Fusaro M, Godoy G, Kim E, Bromberg ME, etal. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Oncogene. 2009; 28: 2756–65. doi: http://dx.doi.org/10.1038/onc.2009.132.
   Google Scholar
• Heidegger I, Massoner P, Sampson N, Klocker H. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer. Cancer Lett. 2015; 367: 113–21. doi: http://dx.doi.org/10.1016/j.canlet.2015.07.026.
   Google Scholar